Transaction in Own Shares

Palace Capital PLC
16 July 2024
 

16 July 2024

Palace Capital plc

("Palace Capital" or the "Company")

Transaction in own shares

The Company announces that it has purchased the following number of its ordinary shares of 10 pence each in the capital of the Company (the "Ordinary Shares") through Numis Securities Limited ("Deutsche Numis") in line with the tender offer announced on 13 June 2024 (the "Tender Offer"). The below purchase concludes the Tender Offer purchases. Following the over subscription for the Tender Offer, Qualifying Shareholders who applied for more than their Guaranteed Entitlement were scaled down to 2.7977% above the Guaranteed Entitlement that such Qualifying Shareholders tendered.

Date of purchase:  16 July 2024

Number of Ordinary Shares purchased:  8,667,760 (eight million, six hundred and sixty seven, seven hundred and sixty) Ordinary Shares

Highest price paid per Ordinary Share:  250.0 pence / Lowest price paid per Ordinary Share:  250.0 pence

Average price paid per Ordinary Share: 250.0 pence

The Company has cancelled these Ordinary Shares. No shares are held in treasury.

Following the above purchase, the total number of shares in issue is 28,892,535 ordinary shares of 10 pence each in the capital of the Company (and no shares are held in treasury). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

Palace Capital plc


Steven Owen, Executive Chairman

info@placecapitalplc.com

 


FTI Consulting

Financial PR

Dido Laurimore, Giles Barrie 

Tel: 0203 727 1000

 


Deutsche Numis

Broker

Oliver Hardy

Heraclis Economides 

Tel: 0207 260 1200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100